Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5853/jos.2015.17.2.127 http://scihub22266oqcxt.onion/10.5853/jos.2015.17.2.127 C4460332!4460332!26060800     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Stroke 2015 ; 17 (2): 127-37 Nephropedia Template TP {{tp|p=26060800|t=2015. Evolution of Endovascular Therapy in Acute Stroke: Implications of Device Development |pdf=|usr=}}{{26060800}} gab.com Text Evolution of Endovascular Therapy in Acute Stroke: Implications of Device Development JO: J Stroke http://www.kidney.de/pget.php?&tw=1&pmid=26060800 #FOAvip Intravenous thrombolysis is an effective treatment for acute ischaemic stroke. However, vascular recanalization rates remain poor especially in the setting of large artery occlusion. On the other hand, endovascular intra-arterial therapy addresses this issue with superior recanalization rates compared with intravenous thrombolysis. Although previous randomized controlled studies of intra-arterial therapy failed to demonstrate superiority, the failings may be attributed to a combination of inferior intra-arterial devices and suboptimal selection criteria. The recent results of several randomized controlled trials have demonstrated significantly improved outcomes, underpinning the advantage of newer intra-arterial devices and superior recanalization rates, leading to renewed interest in establishing intra-arterial therapy as the gold standard for acute ischaemic stroke. The aim of this review is to outline the history and development of different intra-arterial devices and future directions in research. Twit Text FOAVip Evolution of Endovascular Therapy in Acute Stroke: Implications of Device Development ????J Stroke http://www.kidney.de/pget.php?&tw=1&pmid=26060800 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26060800 #FOAvip English Wikipedia <ref>{{Cite pmid|26060800}}</ref> Evolution of Endovascular Therapy in Acute Stroke: Implications of Device Development #MMPMID26060800 Balasubramaian A; Mitchell P; Dowling R; Yan B J Stroke 2015[May]; 17 (2): 127-37 PMID26060800show ga Intravenous thrombolysis is an effective treatment for acute ischaemic stroke. However, vascular recanalization rates remain poor especially in the setting of large artery occlusion. On the other hand, endovascular intra-arterial therapy addresses this issue with superior recanalization rates compared with intravenous thrombolysis. Although previous randomized controlled studies of intra-arterial therapy failed to demonstrate superiority, the failings may be attributed to a combination of inferior intra-arterial devices and suboptimal selection criteria. The recent results of several randomized controlled trials have demonstrated significantly improved outcomes, underpinning the advantage of newer intra-arterial devices and superior recanalization rates, leading to renewed interest in establishing intra-arterial therapy as the gold standard for acute ischaemic stroke. The aim of this review is to outline the history and development of different intra-arterial devices and future directions in research. äEvolution of Endovascular Therapy in Acute Stroke: Implications of Dev(epmc).pdf DeepDyve Pubget Overpricing